Version 1
: Received: 6 January 2024 / Approved: 8 January 2024 / Online: 8 January 2024 (07:14:11 CET)
How to cite:
Chengizkhan, G.; Mohan, M.; Mohammed Rafi, S. T.; Muthusami, S.; Ramalingam, S.; Queimado, L.; Kumaran, R. I.; Narasimhan, S.; Ramachandran, I. Di(2-Ethylhexyl) Phthalate Induces Osteoblast Cytotoxicity through Alterations in the Oxidant-Antioxidant System. Preprints2024, 2024010575. https://doi.org/10.20944/preprints202401.0575.v1
Chengizkhan, G.; Mohan, M.; Mohammed Rafi, S. T.; Muthusami, S.; Ramalingam, S.; Queimado, L.; Kumaran, R. I.; Narasimhan, S.; Ramachandran, I. Di(2-Ethylhexyl) Phthalate Induces Osteoblast Cytotoxicity through Alterations in the Oxidant-Antioxidant System. Preprints 2024, 2024010575. https://doi.org/10.20944/preprints202401.0575.v1
Chengizkhan, G.; Mohan, M.; Mohammed Rafi, S. T.; Muthusami, S.; Ramalingam, S.; Queimado, L.; Kumaran, R. I.; Narasimhan, S.; Ramachandran, I. Di(2-Ethylhexyl) Phthalate Induces Osteoblast Cytotoxicity through Alterations in the Oxidant-Antioxidant System. Preprints2024, 2024010575. https://doi.org/10.20944/preprints202401.0575.v1
APA Style
Chengizkhan, G., Mohan, M., Mohammed Rafi, S. T., Muthusami, S., Ramalingam, S., Queimado, L., Kumaran, R. I., Narasimhan, S., & Ramachandran, I. (2024). Di(2-Ethylhexyl) Phthalate Induces Osteoblast Cytotoxicity through Alterations in the Oxidant-Antioxidant System. Preprints. https://doi.org/10.20944/preprints202401.0575.v1
Chicago/Turabian Style
Chengizkhan, G., Srinivasan Narasimhan and Ilangovan Ramachandran. 2024 "Di(2-Ethylhexyl) Phthalate Induces Osteoblast Cytotoxicity through Alterations in the Oxidant-Antioxidant System" Preprints. https://doi.org/10.20944/preprints202401.0575.v1
Abstract
Humans are often exposed to various environmental contaminants, among which phthalates are prevalent due to their extensive use as plasticizers in various consumer goods. Di(2-ethylhexyl) phthalate (DEHP), a widely used phthalate, is recognized as an endocrine disruptor chemical (EDC). DEHP is reported to affect various organs. Few studies have addressed the effects of phthalates on bone. However, the effects of DEHP on the bone forming cells (osteoblasts) are obscure. The present study was peformed to determine the cytotoxic effects of DEHP on human osteoblasts in vitro and to delineate the mechansims. In this study, we exposed the human osteo-blastic cell line MG-63 to various concentrations of DEHP (1, 25, 50 and 100 µM) for 24, 48 and 72 h. Cell viability was assessed by MTT assay. Total RNA and protein were collected after 48 h treatment with 1 and 100 µM DEHP and determined for the mRNA and/or protein expression of alkaline phosphatase (ALP), sex steroid receptors (androgen and estrogen receptors), receptor activator of nuclear factor kappa-Β ligand (RANKL), runt-related transcription factor 2 (RUNX2) and peroxisome proliferator-activated receptor alpha (PPARα). The mRNA expression was stud-ied by real-time RT-PCR analysis and the protein expression was determined by western blot analysis. Statistical analyses were done by one-way analysis of variance (ANOVA) followed by the Students–Newman–Keuls (SNK) test. The exposure of MG-63 cells to DEHP caused a signifi-cant decrease in osteoblast viability in all the treatment groups and at all the time points stud-ied. Interestingly, DEHP exposure decreased the mRNA expression of ALP, a bone formation marker. DEHP had differential effects on estrogen receptor alpha (ERα) mRNA and protein ex-pression. However, DEHP treatment downregulated the mRNA and protein expression of ERβ, and androgen receptor (AR). Surprisingly, DEHP downregulated the RANKL mRNA expression. DEHP decreased the protein expression of RUNX2, the key transcription factor and master regu-lator of bone formation. Furthermore, DEHP increased the PPARα protein expression in the os-teoblasts. Importantly, DEHP increased the reactive oxygen species (ROS) molecules and thus oxidative stress in osteoblasts, as observed by increased hydrogen peroxide, hydroxyl radical levels and lipid peroxidation. On the other hand, it decreased the enzymatic and non-enzymatic antioxidant levels namely catalase, superoxide dismutase, glutathione peroxidase activity and reduced glutathione. Our study demonstrated that in vitro exposure to DEHP reduces the osteo-blast viability possibly through alterations in the oxidant-antioxidant system and modulation of the key genes involved in bone formation, highlighting the cytotoxic effects of DEHP on bone forming cells.
Keywords
Di(2-ethylhexyl) phthalate (DEHP); Endocrine disrupting compound (EDC); sex steroid receptor; Runt-related transcription factor 2 (Runx2); oxidant-antioxidant system; osteoblastic cells; bone
Subject
Biology and Life Sciences, Endocrinology and Metabolism
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.